Lead Optizmization of a 4-Aminopyridine Benzamide Scaffold to Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors
Journal Article
·
· J. Med. Chem. 56, 4521 (2013)
OSTI ID:1185153
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1185153
- Report Number(s):
- SLAC-REPRINT-2015-029
- Journal Information:
- J. Med. Chem. 56, 4521 (2013), Journal Name: J. Med. Chem. 56, 4521 (2013)
- Country of Publication:
- United States
- Language:
- English
Similar Records
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
Journal Article
·
Tue Aug 21 00:00:00 EDT 2018
· Journal of Medicinal Chemistry
·
OSTI ID:1185153
+67 more
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
Journal Article
·
Wed Apr 22 00:00:00 EDT 2020
· Journal of Medicinal Chemistry
·
OSTI ID:1185153
+7 more
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
Journal Article
·
Mon Mar 08 00:00:00 EST 2010
· J. Med. Chem.
·
OSTI ID:1185153
+11 more